Liquid Biopsy Market Size, Share & Industry Analysis, By Product (Kits & Reagents, and Instruments), By Application (Oncology, Non-invasive Prenatal Testing (NIPT), and Others), By End User (Hospitals, Clinical Laboratories, and Others), and Regional Forecast, 2024-2032

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2023

Estimated Year

2024

Forecast Period

2024-2032

Historical Period

2019-2022

Growth Rate 

CAGR of 25.3% from 2024-2032

Unit

Value (USD Billion)

Segmentation

By Product

• Kits & Reagents
• Instruments

By Application

• Non-invasive Prenatal Testing (NIPT)
• Oncology
• Others

By End User

• Hospitals
• Clinical Laboratories
• Others

By Region

• North America (By Product, By Application, By End User, and By Country)
• U.S. (By Application)
• Canada (By Application)
• Europe (By Product, By Application, By End User, and By Country/ Sub-region)
• Germany (By Application)
• U.K. (By Application)
• France (By Application)
• Italy (By Application)
• Spain (By Application)
• Rest of Europe ((By Application)
• Asia Pacific (By Product, By Application, By End User, and By Country/ Sub-region)
• Japan (By Application)
• China (By Application)
• India (By Application)
• Australia (By Application)
• Southeast Asia (By Application)
• Rest of Asia Pacific (By Application)
• Latin America (By Product, By Application, By End User, and By Country/ Sub-region)
• Brazil (By Application)
• Mexico (By Application)
• Rest of Latin America (By Application)
• Middle East & Africa (By Product, By Application, By End User, and By Country/ Sub-region)
• GCC (By Application)
• South Africa (By Application)
• Rest of Middle East & Africa (By Application)